Objective-To present recent trends in sexually transmitted diseases (STDs) in France and to estimate the gonorrhoea incidence in 1990. Methods-Trends were analysed from data of three surveillance systems: (1) 
networks in 1985. The rate of PPNG strains has regularly increased in the laboratory network to reach 14% in 1991. Data suggest that the incidence in some acute non recurrent STDs could have increased among homo/bisexual men since 1988. Chlamydia trachomatis is now the most frequent diagnosis in STD clinics. Estimation of male gonorrhoea incidence rate in France in 1990 of 741100 000 inhabitants (15-59 years) is consistent with figures observed in England and Wales, where the age distribution is very similar. On the other hand, the estimated female gonorrhoea incidence rate of 141100 000, which concerns only microbiologically ascertained cases, is one third in France than that observed in England and Wales. Conclusion-The consistency of the decreasing trends in gonorrhoea and acute male urethritis observed from the different networks reduces the possibility of a bias due to any change in notification or in prescription. Trends in Chlamydia trachomatis will be better appraised in the near future with the recent implementation of new systems. The French STD surveillance appears quite satisfactory for male infections and has been able to show a marked decrease in the incidence of some STDs in the last years. Surveillance of female STDs is to be improved, in terms of monitored diagnoses and selected health care facilities. Differences between the female gonorrhoea incidence rate observed in England and Wales and the one computed for France could be attributed to differences in contact tracing policies between the two countries or to differences in sexual lifestyles. (Genitourin Med 1994; 70:15-21) Introduction Surveillance of sexually transmitted diseases (STDs) is of particular importance in France, since it is the European country with the greatest number of AIDS cases (25 555 In order to assess the representativity of RENAGO, a study (the "National Laboratory Study") was performed in 1992 among a national random sample of one seventh of all the 4193 microbiological laboratories. They were asked to state how many gonococcal infections they had diagnosed during 1991. The response rate was 88%. This study allowed us to compute a mean number of isolated gonorrhoea strains per laboratory per year. The sex-ratio observed in RENAGO was applied to these results to compute a mean number by sex. As no laboratory working with an STD clinic was included in the sample, this mean number was considered to reflect the "routine" activity of French laboratories. Cases from STD clinics had therefore to be added in order to estimate incidence by sex in microbiologically ascertained gonorrhoea in France.
In order to asses how many cases of gonorrhoea could be missed when only microbiologically ascertained cases are taken into account, data from other studies were used. One is a randomised community trial of prevention of STDs,"1 where a sample of 263 GPs in six French departments (administrative area comprising about 600 000 inhabitants) were asked to describe all cases of urethral or vaginal discharge among their patients. We will refer to this study as the "six Department-Study". The second one is a GP network set up in Aquitaine, a French region (administrative area comprising about 3 millions of inhabitants), which has monitored male urethritis from October 1987 to 14000:
October 1990.1213 Information about the diagnosis and its mode was collected from the Gonorrhoea hundred GPs who participated. We will refer to this study as the "Aquitaine network". 12 
000
These studies allowed us to estimate the proportion of male cases of gonorrhoea seen in general practice which are microbiologically diagnosed. Our estimation of male microbio-10 000 X logically ascertained gonorrhoea incidence was divided by this proportion to obtain the incidence in male gonorrhoea in France. In 1990 in Paris STD clinics, the rate of PPNG (Penicillinase Producing Neisseria There is no major trend in the mean age of men and women with positive isolates. Although they were very few, men with gonococcal proctitis in 1990 seemed older than men with gonococcal urethritis (mean age of respectively 37-0 and 29-6 years). 14-2/100 000 inhabitants (15-59 years). We have no other source of data to assess how many cases of female gonorrhoea are overlooked when only microbiologically ascertained cases are taken into account. Discussion French STD surveillance is based on data from different systems. These systems use different definitions of STD cases, either clinical or microbiological. They probably also involve different types of patients, as suggested by the comparison between networks of age and sex-ratio of the cases. A higher M/F sex-ratio in gonorrhoea cases was observed in 1990 in Paris STD clinics (9.7) than in RENAGO in the Paris area (6X1). This is unlikely to reflect differences in diagnostic protocols between the sexes according to the health care facility. As almost all the men with urethritis and women with cervicovaginitis in Paris STD clinics undergo a microbiological investigation, this would lead us to consider the high sex-ratio of almost 10 observed in STD clinics as the reference. It appears more likely that the attendance patterns of homosexual men could explain this difference in sex-ratio between networks: 40% of male gonorrhoea cases in Paris STD clinics were homo/bisexual and a higher proportion of homo/bisexual was found among male cases in Paris STD clinics (25%) than among male urethritis in the FCDN within the Paris area (16%). The National Sexual Behaviour Study, which has been recently held among 20 000 French residents,14 will give us useful insights to understand the attendance patterns of different groups of the population at different types of health care facilities. Moreover, the routine specification of sexual orientation of cases, whilst delicate to request from private laboratories, could easily be implemented in STD clinics.
Nevertheless, the consistency of the declining trends in gonorrhoea and male acute urethritis observed from the different networks throughout the last years reduces the possibility of a bias due to any change in attendance, notification or prescription. Finally, incidence rates are not easy to estimate with routine data from the systems, since it was not their objective when first implemented. Major efforts have been rather aimed at maintaining a high rate of participa-tion among the same sample of volunteers in order to present valid trends. In this paper gonorrhoea incidence in France in 1990 has been estimated by using several sources of data. Our estimation of the gonorrhoea incidence rate was of around 74 for maie and 14 for female cases/100 000 inhabitants (15-59 years). In England and Wales, where the age distribution of the population is similar, gonorrhoea incidence rates for male and female in 1990 were respectively around 71 and 47 cases/100 000 inhabitants (15-59 years) (16 and M Catchpole personal data). Our estimation of male gonorrhoea incidence is close to the rate observed in England and Wales. On the other hand, the estimation for female cases, which concerns only microbiologically ascertained cases, is one third in France of that in England and Wales. Contact tracing policies differ between the two countries. In France, presumptive treatment (without a laboratory confirmation) occurs in private practice and is certainly more frequently applied to female partners of infected cases, often asymptomatic, than to male ones. Although treated, these women would have no microbiological diagnosis and would thus not be included in our sentinel networks. We may also have missed high-risk women, such as occasional prostitutes who can practice self-medication,25 but their number is unlikely to explain all the discrepancy. Finally, differences in sexual lifestyles could explain different incidence rates in gonorrhoea. The comparison of sexual behaviours from the National Studies which were held in France'4 and in England and Wales26 will certainly provide useful information. Whatever the explanation, this confirms that the French STD surveillance system, although appearing quite satisfactory for trends in male infections, should be improved concerning female STDs, both in terms of selected health care services and of monitored diagnoses. Information should also be collected in some facilities to more precisely describe characteristics of people with an STD.
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